Tom Willis
Oncology
Adaptive Biotechnologies
United States of America
Biography
Dr. Willis previously oversaw the product development and clinical validation of Adaptive’s diagnostic products. He previously served as the CEO and Co-founder of Sequenta, Inc. (acquired by Adaptive in 2015). Prior to Adaptive, Dr. Willis co-founded ParAllele BioScience (acquired by Affymetrix in 2005). He also co-invented Molecular Inversion Probe technology for high throughput genotyping, while at the Stanford Genome Technology Center. Dr. Willis received his Ph.D. in physics from Stanford University.
Research Interest
Oncology
